Challenges and opportunities to end tuberculosis in the COVID-19 era

Authors: Karmadwala, Fatima;

MacPherson, Peter;

Millington, Kerry A.;

Walker, Naomi F.;

Cuevas, Luis E.;

Squire, S. Bertel;

Wingfield, Tom

Source: The Lancet Respiratory Medicine

Full text

: http://dx.doi.org/10.1016/s2213-2600(21)00161-2

Abstract

On World Tuberculosis Day, 2020, we warned of the impending impact of COVID-19 on the tuberculosis pandemic. We also made a plea that the world must not forget tuberculosis while it focused on COVID-19.

1 year later, on World Tuberculosis Day, 2021, we reflect on the compelling evidence of the challenges that COVID-19 has created for tuberculosis control and look forward to opportunities for integrated strategies to address the COVID-19 and tuberculosis pandemics.

Rights

This content is not covered by the Open Government Licence. Please see source record or item for information on rights and permissions.

Cite as

Karmadwala, F., MacPherson, P., Millington, K., Walker, N., Cuevas, L., Squire, S. & Wingfield, T. 2021, 'Challenges and opportunities to end tuberculosis in the COVID-19 era', The Lancet Respiratory Medicine, 9(6), pp. 556-558. http://dx.doi.org/10.1016/s2213-2600(21)00161-2

Downloadable citations

HTML BIB RIS

Identifiers

DOI: http://dx.doi.org/10.1016/s2213-2600(21)00161-2

Repository URI: https://eprints.gla.ac.uk/290462/